Lipocine

LPCNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$17.560 M

$2.13 +0.00%

Close of 7 Aug 2026

Revenue

$1.98M

#3441 by revenue

Earnings

-$9.63M

Loss-making

Shares outstanding

8,244,253

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#405Skye BioscienceSKYE$18.3M
#406NewcelXNCEL$17.8M
#407LipocineLPCN$17.6M
#408Pasithea TherapeuticsKTTA$16.9M
#409Cyclerion TherapeuticsCYCN$16.7M

Where these numbers come from

Share counts and financials for Lipocine are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.